146 related articles for article (PubMed ID: 9413181)
1. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of phenothiazine-related compounds.
Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
[TBL] [Abstract][Full Text] [Related]
3. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
4. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
5. The in vitro antitumor assay of 5-(Z)-arylidene-4-imidazolidinones in screens of AIDS-related leukemia and lymphomas.
Al-Madi SH; Al-Obaid AM; El-Subbagh HI
Anticancer Drugs; 2001 Nov; 12(10):835-9. PubMed ID: 11707651
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 1-[2-(chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkyl- 1-urea s as potent anticancer agents.
Motohashi N; Kawase M; Kurihara T; Hevér A; Nagy S; Ocsocvszki I; Tanaka M; Molnár J
Anticancer Res; 1996; 16(5A):2525-32. PubMed ID: 8917346
[TBL] [Abstract][Full Text] [Related]
7. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
[TBL] [Abstract][Full Text] [Related]
8. Chemical structure and tumor type specificity of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Sakagami H; Szabo D; Csuri K; Molnár J
Anticancer Res; 1999; 19(3A):1859-64. PubMed ID: 10470128
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
Petri IB; Szekeres E; Varga E; Berek I; Molnár J; Berek L; Kawase M; Motohashi N
Anticancer Res; 1996; 16(3A):1247-50. PubMed ID: 8702245
[TBL] [Abstract][Full Text] [Related]
10. Electronic structure and cytotoxic activity of "half-mustard type" phenothiazines by MM3 and PM3 methods.
Kurihara T; Nojima K; Sakagami H; Motohashi N; Molnár J
Anticancer Res; 1999; 19(5B):3895-9. PubMed ID: 10628328
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl-phenothiazines.
Kurihara T; Motohashi N; Sakagami H; Molnár J
Anticancer Res; 1999; 19(5B):4081-3. PubMed ID: 10628357
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor mechanism of 3-bromopropionylamino benzoylurea on leukemia and lymphoma].
Li JN; Song DQ; Jiang JD
Yao Xue Xue Bao; 2004 Jul; 39(7):491-5. PubMed ID: 15493834
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
Motohashi N; Sakagami H; Kamata K; Yamamoto Y
Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
[TBL] [Abstract][Full Text] [Related]
14. Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity.
Bacherikov VA; Chou TC; Dong HJ; Zhang X; Chen CH; Lin YW; Tsai TJ; Lee RZ; Liu LF; Su TL
Bioorg Med Chem; 2005 Jun; 13(12):3993-4006. PubMed ID: 15911312
[TBL] [Abstract][Full Text] [Related]
15. Correlation between structure and diverse biological activities of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Satoh K; Sakagami H; Molnár J
Anticancer Res; 1997; 17(6D):4403-6. PubMed ID: 9494541
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
Lacroix J; Gaudreault RC; Pagé M; Joly LP
Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
[TBL] [Abstract][Full Text] [Related]
17. Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1 -ureas .
Komatsu N; Motohashi N; Fujimaki M; Molnár J
In Vivo; 1997; 11(1):13-6. PubMed ID: 9067767
[TBL] [Abstract][Full Text] [Related]
18. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
19. Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models.
Waud WR; Gilbert KS; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2012; 31(9):647-60. PubMed ID: 23004929
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives.
Li HQ; Zhu TT; Yan T; Luo Y; Zhu HL
Eur J Med Chem; 2009 Feb; 44(2):453-9. PubMed ID: 18514972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
